Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -9.20 | 14.31 |
| PEG Ratio (TTM) | -1.66 | -4.80 |
| P/S Ratio (TTM) | 0.30 | 2.16 |
| P/B Ratio (TTM) | 0.68 | 6.09 |
| P/FCF Ratio (TTM) | 7.55 | 20.82 |
| Price to 5YR AVG Earnings Ratio | N/A | 26.09 |
| Price to 5YR AVG FCF Ratio | N/A | 29.04 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.55% | 9.28% |
| ROE (TTM) | -7.34% | 40.46% |
| Net Profit Margin (TTM) | -3.31% | 13.43% |
| ROIC 5YR AVG | N/A | 14.83% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -62.90% | 2.84% | N/A |
| Revenue | -6.79% | 7.69% | N/A |
| Net Income | -63.17% | 2.64% | N/A |
| Cash Flow | 374.84% | -8.20% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.55 | 2.28 |
| Quick Ratio (TTM) | 0.37 | 1.80 |
| D/E Ratio (TTM) | 0.58 | 2.05 |
| Interest Coverage (TTM) | 0.04 | 14.63 |
| Piotroski F-Score | 5 | 7 |
| Altman Z-Score | 2.06 | 3.45 |
| LTL to 5YR AVG FCF | N/A | 7.13 |
| Shares Outstanding Growth 5YR AVG | N/A | -2.07% |